z-logo
open-access-imgOpen Access
Specific Immunoassay Reveals Increased Serum Trypsinogen 3 in Acute Pancreatitis
Author(s) -
Jani Oiva,
Outi Itkonen,
Riitta Koistinen,
Kristina Hotakainen,
Wangming Zhang,
Esko Kemppainen,
Pauli Puolakkainen,
Leena Kylänpää,
UlfHåkan Stenman,
Hannu Koistinen
Publication year - 2011
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2011.167965
Subject(s) - trypsinogen , immunoassay , acute pancreatitis , pancreatitis , medicine , endocrinology , gastroenterology , chemistry , immunology , antibody , biochemistry , enzyme , trypsin
Trypsinogen 3 is a minor trypsinogen isoform in the pancreas. In contrast with trypsin 1 and 2, trypsin 3 degrades pancreatic secretory trypsin inhibitor, which may lead to an excess of active trypsin and acute pancreatitis (AP). We developed an immunoassay for trypsinogen 3 and studied whether an assay of serum trypsinogen 3 is of clinical utility in the diagnosis of AP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom